CERA-STATTM HBA1C TEST KIT
EL KIT DE PRUEBA DE HBA1C CERA-STATTM ESTÁ DESTINADO PARA LA DETERMINACIÓN CUANTITATIVA DE HEMOGLOBINA GLUCOSILADA EN SANGRE HUMANA. TAMBIÉN PROPORCIONA EL VALOR PROMEDIO DE LA GLUCOSA (EAG). AGENTE DE DIAGNÓSTICO PARA USO IN VITRO.
THE CERA-STATTM HBA1C TEST KIT IS INTENDED FOR THE QUANTITATIVE DETERMINATION OF GLYCOSYLATED HEMOGLOBIN IN HUMAN BLOOD. IT ALSO PROVIDES THE AVERAGE GLUCOSE VALUE (EAG). DIAGNOSTIC AGENT FOR IN VITRO USE.
- Risk Class / Clase de Riesgo
- Clase I
- Product Type (Spanish)
- III. AGENTES DE DIAGNÓSTICO
- Product Type (English)
- III. DIAGNOSTIC AGENTS
- Trade Name (Spanish)
- KIT PARA LA DETERMINACIÓN DE HBA1C EN SANGRE HUMANA
- Trade Name (English)
- KIT FOR THE DETERMINATION OF HBA1C IN HUMAN BLOOD
- Analysis ID
- 3R2019 SSA
- Registration Date
- January 14, 2019
- Name (Spanish)
- DISTRIBUIDORA QUÍMICA INTEGRAL, S.A. DE C.V.
- Name (English)
- DISTRIBUIDORA QUÍMICA INTEGRAL, S.A. DE C.V.
Access comprehensive regulatory information for CERA-STATTM HBA1C TEST KIT (CERA-STATTM HBA1C TEST KIT) in the Mexico medical device market through Pure Global AI's free database. This Clase I medical device is registered under COFEPRIS analysis ID 3R2019 SSA and manufactured by DISTRIBUIDORA QUÍMICA INTEGRAL, S.A. DE C.V.. The device was registered on January 14, 2019.
This page provides complete registration details including product type (III. DIAGNOSTIC AGENTS), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.